STAGE IVA LUNG CANCER AJCC V8
Clinical trials for STAGE IVA LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs (durvalumab and tremelimumab) plus a targeted therapy (selumetinib) in 40 people with advanced non-small cell lung cancer that had returned. The goal was to find the safest dose and see if the combination could shrink tum…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New hope for drug-resistant lung cancer: combo therapy tested in early trial
Disease control CompletedThis early-phase trial tested two experimental drug combinations in 37 people with advanced EGFR-mutant lung cancer that no longer responded to the targeted therapy osimertinib. The goal was to find safe, tolerable doses of alisertib or sapanisertib when given together with osime…
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New program aims to boost strength and mood in older lung cancer patients
Symptom relief CompletedThis study tested a supportive care program for adults aged 60 and older with advanced lung cancer. The program combined physical therapy and relaxation exercises to help improve physical function and emotional wellbeing. Researchers measured how well participants stuck with the …
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC
-
Cancer moonshot study banks samples to unlock genetic secrets
Knowledge-focused CompletedThis study collected tumor tissue and blood samples from 64 people with advanced or treatment-resistant cancers. The goal was to store these samples for future research on how genes affect cancer and response to treatment. No direct treatment was given; the focus was on building …
Matched conditions: STAGE IVA LUNG CANCER AJCC V8
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC